相似文献
1
The clinical utility of newer antidepressant agents: Understanding the role in management of MDD.
Ment Health Clin. 2022 Nov 3;12(5):309-319. doi: 10.9740/mhc.2022.10.309. eCollection 2022 Oct.
2
The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone.
Neuropsychiatr Dis Treat. 2017 Nov 29;13:2913-2919. doi: 10.2147/NDT.S150589. eCollection 2017.
3
Cost-effectiveness of vortioxetine compared with levomilnacipran and vilazodone in patients with major depressive disorder switching from an initial antidepressant.
Expert Rev Pharmacoecon Outcomes Res. 2021 Feb;21(1):29-42. doi: 10.1080/14737167.2021.1855979. Epub 2021 Jan 17.
4
A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine.
Expert Opin Pharmacother. 2014 Dec;15(17):2525-42. doi: 10.1517/14656566.2014.960842. Epub 2014 Sep 16.
5
Efficacy and safety of levomilnacipran, vilazodone and vortioxetine compared with other second-generation antidepressants for major depressive disorder in adults: A systematic review and network meta-analysis.
J Affect Disord. 2018 Mar 1;228:1-12. doi: 10.1016/j.jad.2017.11.056. Epub 2017 Nov 16.
6
Other Antidepressants.
Handb Exp Pharmacol. 2019;250:325-355. doi: 10.1007/164_2018_167.
7
New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Cochrane Database Syst Rev. 2021 May 24;5(5):CD013674. doi: 10.1002/14651858.CD013674.pub2.
8
Efficacy and tolerability of different doses of three new antidepressants for treating major depressive disorder: A PRISMA-compliant meta-analysis.
J Psychiatr Res. 2018 Jan;96:247-259. doi: 10.1016/j.jpsychires.2017.10.018. Epub 2017 Oct 21.
9
Inclusion/exclusion criteria in placebo-controlled studies of vortioxetine: Comparison to other antidepressants and implications for product labeling.
J Affect Disord. 2016 Jan 15;190:357-361. doi: 10.1016/j.jad.2015.10.041. Epub 2015 Oct 25.
10
The Black Book of Psychotropic Dosing and Monitoring.
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
引用本文的文献
1
Switching to Vortioxetine in Patients with Poorly Tolerated Antidepressant-Related Sexual Dysfunction in Clinical Practice: A 3-Month Prospective Real-Life Study.
J Clin Med. 2024 Jan 18;13(2):546. doi: 10.3390/jcm13020546.
本文引用的文献
1
The Management of Major Depressive Disorder: Synopsis of the 2022 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline.
Ann Intern Med. 2022 Oct;175(10):1440-1451. doi: 10.7326/M22-1603. Epub 2022 Sep 20.
2
The Prevalence and National Burden of Treatment-Resistant Depression and Major Depressive Disorder in the United States.
J Clin Psychiatry. 2021 Mar 16;82(2):20m13699. doi: 10.4088/JCP.20m13699.
3
Antidepressant Use Among Adults: United States, 2015-2018.
NCHS Data Brief. 2020 Sep(377):1-8.
4
Antidepressant-induced sexual dysfunction.
Med J Aust. 2020 Apr;212(7):329-334. doi: 10.5694/mja2.50522. Epub 2020 Mar 15.
5
Spatial Aggregation Net: Point Cloud Semantic Segmentation Based on Multi-Directional Convolution.
Sensors (Basel). 2019 Oct 7;19(19):4329. doi: 10.3390/s19194329.
6
Relationship of cognitive impairment with depressive symptoms and psychosocial function in patients with major depressive disorder: Cross-sectional analysis of baseline data from PERFORM-J.
J Affect Disord. 2019 Nov 1;258:172-178. doi: 10.1016/j.jad.2019.07.064. Epub 2019 Jul 30.
7
Paroxetine, but not Vortioxetine, Impairs Sexual Functioning Compared With Placebo in Healthy Adults: A Randomized, Controlled Trial.
J Sex Med. 2019 Oct;16(10):1638-1649. doi: 10.1016/j.jsxm.2019.06.018. Epub 2019 Aug 9.
8
Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China.
Neuropsychiatr Dis Treat. 2019 Jul 1;15:1723-1736. doi: 10.2147/NDT.S195505. eCollection 2019.
9
Clinical implications of directly switching antidepressants in well-treated depressed patients with treatment-emergent sexual dysfunction: a comparison between vortioxetine and escitalopram.
CNS Spectr. 2020 Feb;25(1):50-63. doi: 10.1017/S1092852919000750.
10
Cognitive-functional relationships in major depressive disorder: Crucial data from a Ukrainian open-label study of vortioxetine versus escitalopram.
J Affect Disord. 2019 May 1;250:114-122. doi: 10.1016/j.jad.2019.03.040. Epub 2019 Mar 5.
Zotero 插件